Bio-Ocean

Executive Summary

Bio-Ocean is a privately held company based in San Diego, founded in 2003, specializing in the development and distribution of high-quality immunoassay products for biological and clinical research. The company offers a broad portfolio of antibodies and immunoassay kits, serving researchers worldwide through a network of dedicated distributors. With a focus on scientific discovery, Bio-Ocean positions itself as a reliable supplier of reagents essential for advancing biomedical research. Despite being a long-standing player in the market, the company operates with limited public visibility, as it is privately held and does not disclose financial performance or funding history. Its competitive edge lies in the quality and consistency of its products, which are critical for reproducibility in research. However, the lack of differentiated technology or proprietary platforms suggests that growth may be driven by expansion into new geographic markets or through strategic partnerships with larger life science companies.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation antibody panel for oncology research60% success
• Q3 2026Strategic distribution agreement with a major European life science distributor70% success
• Q1 2027Introduction of a new biomarker discovery line for neurodegenerative diseases50% success